VC
BHC icon

Vicus Capital’s Bausch Health BHC Stock Holding History

Vicus Capital’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,130
Closed -$202K – 206
2015
Q3 		$202K Hold
1,130
– – 0.05% 161
2015
Q2 		$251K Buy
1,130
+194
+21% +$43K 0.07% 152
2015
Q1 		$186 Sell
936
-646
-41% -$115K 0.04% 176
2014
Q4 		$226K Buy
+1,582
New +$213K 0.07% 149

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vicus Capital's BHC Position: Q4 2015 in Review

Vicus Capital sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 1,130 shares — an estimated $202K sold.

Vicus Capital first reported a position in BHC in Q4 2014 and held it in 4 quarters. The position peaked at $251K in Q2 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Vicus Capital reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Vicus Capital sold 1,130 Bausch Health shares in Q4 2015, an estimated $202K.
  • Vicus Capital first reported a position in Bausch Health in Q4 2014 and held it in 4 quarters.
  • Vicus Capital's Bausch Health position peaked at $251K in Q2 2015.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Vicus Capital's 13F filing for Q4 2015, filed 13 Jan 2016.